Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06203249

Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease

Microecology and Host Immunity in Patients With Anti-melanoma Differentiation Associated Gene 5 Antibody Positive Dermatomyositis and Interstitial Lung Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to analyze the relationship between the microbial community, host immunity and the presence or absence of concurrent rapidly progressive interstitial lung disease patients with anti-MDA5 antibody positive dermatomyositis.

Detailed description

Methods: Bronchoalveolar lavage specimens of patients with anti-MDA5 antibody positive dermatomyositis and interstitial lung disease were collected and studied to analyze the relationship between the composition of patients' microecology and the occurrence and development of disease.

Conditions

Timeline

Start date
2024-01-20
Primary completion
2025-12-30
Completion
2026-11-25
First posted
2024-01-12
Last updated
2024-01-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06203249. Inclusion in this directory is not an endorsement.

Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease (NCT06203249) · Clinical Trials Directory